FDA Releases Guidance for Industry on IND Meetings for Human Drugs and Biologics

Summary

The Food and Drug Administration (FDA) has made available a guidance document outlining recommendations for formal meetings between pharmaceutical companies and the FDA on chemistry, manufacturing, and controls information for human drugs and biologics.